Health
Start-up awarded grant to develop contrast agent for early detection of liver disease – EurekAlert
Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Instit…
ATLANTA–Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Institute of Health grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis, formation of scar tissue in the liver caused by alcoholic and non-alcoholic fatty liver disease.
“We have been working on this breakthrough in the lab for several years,” said Yang. “This funding will help us to…
-
General17 hours agoStar Wars’ fascist dystopia has never felt closer than in new season of Andor
-
General21 hours agoCoalition to chart path forward as family feud cooled
-
Noosa News20 hours agoInterest rates: Why we will keep paying the same repayments
-
Noosa News17 hours agoQueensland Premier David Crisafulli keeps clear of Coalition chaos in Canberra